Stay updated on Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial
Sign up to get notified when there's something new on the Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial page.

Latest updates to the Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a technical site release rather than a change to the underlying trial record.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the study record history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a new Study Status entry on 2026-03-30 (version 35) and deleted content from 2025-02-06.SummaryDifference0.3%

- Check49 days agoChange DetectedRevision history updated to add Revision: v3.5.0 and remove Revision: v3.4.3.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision history now shows Revision: v3.4.3 in place of v3.4.2. The rest of the page content remains unaffected.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.2 was added to the history, and the previous operating-status notice from v3.4.1 was removed.SummaryDifference0.5%

Stay in the know with updates to Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fc-Engineered Anti-CTLA-4 in Advanced Cancer Clinical Trial page.